NextCure, Inc. — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2021-03-15

Reporting Person: Langermann Sol (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Employee Stock Option (Right to Buy)	$12.59	A	100000	Acquired	2031-03-14	Common Stock (100000)	Direct

Footnotes

F1: One fourth of the option vests on March 15, 2022. The remainder vests in 36 monthly installments beginning on April 15, 2022.